The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: a qualitative report

Article

<< Previous

Next >>

Contents Vol 9(5)

doi:10.1071/SH11181

Publishing on sexual health from the widest perspective

	Search




	Advanced Search



	Journal Home

	About the Journal

	Editorial Committee

	Contacts



	Content

	Online Early

	Current Issue

	Just Accepted

	All Issues

	Online Early

	Special Issues

	Sample Issue



	For Authors

	General Information

	Instructions to Authors

	Submit Article

	Open Access



	For Referees

	Referee Guidelines

	Review Article

	Annual Referee Index



	For Advertisers



	For Subscribers

	Subscription Prices

	Customer Service

	Print Publication Dates

e-Alerts

Subscribe to our Email Alert or

feeds for the latest journal papers.

Connect with us

Interview with Kit Fairley

Hear Kit Fairley speak about what is sexual health.

The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: a qualitative report

Susan Herrmann ^A ^E , Joan Wardrop ^B , Mina John ^A ^C , Silvana Gaudieri ^D , Michaela Lucas ^A , Simon Mallal ^A and David Nolan ^A ^C

^A Institute for Immunology & Infectious Diseases, Royal Perth Hospital & Murdoch University, Perth, WA 6150, Australia.
^B School of Social Sciences & Asian Languages, Curtin University, Bentley, WA 6012, Australia.
^C Department of Clinical Immunology & PathWest Laboratory Medicine, Royal Perth Hospital, Perth, WA 6000, Australia.
^D School of Anatomy, Physiology and Human Biology, University of Western Australia, Perth, WA 6009, Australia.
^E Corresponding author. Email: s.herrmann@murdoch.edu.au

Sexual Health 9(5) 407-413 http://dx.doi.org/10.1071/SH11181
Submitted: 16 December 2011 Accepted: 2 April 2012 Published: 20 August 2012





	PDF (138 KB) $25



	Export Citation

Print

Abstract

Background: In Australia, temporary visa holders are ineligible for Medicare and subsidised antiretroviral drugs. Additionally, HIV testing is not mandatory for visas unless applicants seek work in the health sector. We sought to understand the impact of HIV and issues of access and adherence to antiretroviral therapy (ART) in people holding temporary visas and permanent residents. Methods: Data were gathered from interviews with 22 participants. Information concerning medication adherence, side effects, CD4 T-cell count, viral load and rate of response to generic drugs were collected. Results: The mean age was 33.4 years (±s.d. = 6.0), 21 out of 22 were from HIV-prevalent areas in East Africa and Asia, 14 out of 22 were on temporary visas, 12 were ineligible for Medicare, 14 out of 22 were diagnosed during health screening, 19 out of 22 risk exposures were in country of origin, 8 out of 17 were taking generic ART at an average cost of $180 per month, adherence was excellent and self-reported side-effects were relatively infrequent. Participants applying for visa continuations and permanent residency were fearful, believing their HIV serostatus would prejudice their applications. Patients cited belief in ART efficacy, were motivated to maintain therapy and were anxious about lack of access to treatment in their countries of origin. Conclusion: Adherence to antiretroviral drugs in Medicare-ineligible HIV-infected individuals is excellent despite limited access to treatment. The threat of visa non-renewal and the likely failure of applications for permanent residency result in considerable anxiety and confidentiality concerns.

Additional keywords: AIDS, antiretroviral therapy, generic drugs, guest workers, immigration, stigma.

References

[1] Combs BC, Giele CM. An increase in overseas acquired HIV infections among heterosexual people in Western Australia. Sex Health 2009; 6: 35–9.
| CrossRef | PubMed |

[2] The International Labour Office. International labour conference report VI International Labour Conference 98th session. Geneva: International Labour Organisation; 2009.

[3] Department of Immigration and Citizenship (DOIAC). Immigration update July to December 2010. Canberra: DOIAC; 2010.

[4] Department of Immigration and Citizenship (DOIAC). Form 1071i health requirement for permanent entry into Australia. Canberra: DOIAC; 2010. Available online at: http://www.immi.gov.au/media/fact-sheets/22health.htm [verified March 2011].

[5] ‘t Hoen EFM. The global politics of pharmaceutical monopoly power. Diemen, Netherlands: AMB Publishers, University of Amsterdam; 2009. Available online at: www.msfaccess.org/content/global-politics-pharmaceutical-monopoly-power [verified February 2012].

[6] Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee – a Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care 2000; 12: 255–66.
| CrossRef | CAS | PubMed |

[7] Justice AC, Holmes W, Gifford AL, Rabeneck L, Zackin R, Sinclair G, et al Development and validation of a self-completed HIV symptom index. J Clin Epidemiol 2001; 54: S77–90.
| CrossRef | PubMed |

[8] Duracinsky M, Herrmann S, Berzins B, Armstrong A, Kohli R, Le Coeur S, et al The development of PROQOL-HIV: an international instrument to assess the health-related quality of life of persons living with HIV/AIDS. J Acquir Immune Defic Syndr 2012; 59: 498–505.
| PubMed |

[9] Carrillo JE, Green AR, Betancourt JR. Cross-cultural primary care: a patient-based approach. Ann Intern Med 1999; 130: 829–34.
| CAS | PubMed |

[10] Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 2010; 375: 2092–8.
| CrossRef | PubMed |

[11] Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853–60.
| CrossRef | PubMed |

[12] Parienti JJ, Das-Douglas M, Massari V, Guzman D, Deeks SG, Verdon R, et al Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels. PLoS ONE 2008; 3: e2783.
| CrossRef | PubMed |

[13] Körner H. HIV and migration: two major uncertainties for people from culturally and lingusitically diverse backgrounds. Sydney : National Centre in HIV Social Research University of NSW; 2005.

[14] Körner H. ‘If I had my residency I wouldn’t worry’: negotiating migration and HIV in Sydney, Australia. Ethn Health 2007; 12: 205–25.
| CrossRef | PubMed |

[15] Körner H. Negotiating cultures: disclosure of HIV-positive status among people from minority ethnic communities in Sydney. Cult Health Sex 2007; 9: 137–52.
| CrossRef | PubMed |

[16] Herrmann S, McKinnon E, John M, Hyland N, Martinez OP, Cain A, et al Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of care. Intern Med J 2008; 38: 8–15.
| CAS | PubMed |

[17] Waldrop-Valverde D, Jones DL, Jayaweera D, Gonzalez P, Romero J, Ownby RL. Gender differences in medication management capacity in HIV infection: the role of health literacy and numeracy. AIDS Behav 2009; 13: 46–52.
| CrossRef | PubMed |

[18] Bulsara C, McKenzie A, Sanfilippo F, Holman CDJ, Emery JE. Not the full Monty: a qualitative study of seniors’ perceptions of generic medicines in Western Australia. Aust J Primary Health 2010; 16: 240–5.
| CrossRef |

[19] Lemoh CN, Baho S, Grierson J, Hellard M, Street A, Biggs BA. African Australians living with HIV: a case series from Victoria. Sex Health 2010; 7: 142–8.
| CrossRef | PubMed |

[20] Orton LC. Seeking asylum and living with HIV: an ethnographic study. Manchester: The University of Manchester; 2009.

[21] Posse M, Meheus F, Van Asten H, Van der Ven A, Baltussen R. Barriers to access to antiretroviral treatment: a review of recent studies in developing countries. Trop Med Int Health 2008; 13: 904–13.
| CrossRef | PubMed |

[22] Logie C, Gadalla TM. Meta-analysis of health and demographic correlates of stigma towards people living with HIV. AIDS Care 2009; 21: 742–53.
| CAS | PubMed |

[23] Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS Behav 2009; 13: 1160–77.
| CrossRef | PubMed |

[24] Stafford A. HIV migrants to be watched. The Age 31 May 2007; : 31.

[25] Antonovsky A. The structural sources of salutogenic strengths. In Cooper CL, Pavne R, editors. Personality and stress: individual differences in the stress process. Chichester: Wiley; 1991. p. 97–102.

[26] Bonnano GA. Loss, trauma and human resilience. Am Psychol 2004; 59: 20–8.

[27] Hood JE, Friedman AL. Unveilling the hidden epidemic: a review of stigma associated with sexually transmissable infections. Sex Health 2011; 8: 159–70.
| CrossRef | PubMed |

[28] The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2011. Sydney: The Kirby Institute, University of New South Wales; 2011.

Subscriber Login

	Username: Password:

Legal & Privacy | Contact Us | Help